Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

365 ARTÍCULOS , VIENDO DEL 1 AL 15

Potential Role of (-)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease

Xicota L, Rodriguez-Morato J, Dierssen M, de la Torre R.

Curr Drug Targets. 2017;18(2):174-195. doi: 10.2174/1389450116666150825113655.

CADD Modeling of Multi-Target Drugs Against Alzheimer's Disease

Ambure P, Roy K.

Curr Drug Targets. 2017;18(5):522-533. doi: 10.2174/1389450116666150907104855.

Effect of Genetic Polymorphisms (SNPs) in CHRNA7 Gene on Response to Acetylcholinesterase Inhibitors (AChEI) in Patients with Alzheimer's Disease

Russo P, Kisialiou A, Moroni R, Prinzi G, Fini M.

Curr Drug Targets. 2017;18(10):1179-1190. doi: 10.2174/1389450116666151001111826.

Multi-Target Mining of Alzheimer Disease Proteome with Hansch's QSBR-Perturbation Theory and Experimental-Theoretic Study of New Thiophene Isosters of Rasagiline

Abeijon P, Garcia-Mera X, Caamano O, Yanez M, Lopez-Castro E, Romero-Duran FJ, Gonzalez-Diaz H.

Curr Drug Targets. 2017;18(5):511-521. doi: 10.2174/1389450116666151102095243.

Rexinoids as Therapeutics for Alzheimer's Disease: Role of APOE

Koster KP, Smith C, Valencia-Olvera AC, Thatcher GR, Tai LM, LaDu MJ.

Curr Top Med Chem. 2017;17(6):708-720. doi: 10.2174/1568026616666160617090227.

The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease

Karl T, Garner B, Cheng D.

Behav Pharmacol. 2017 Apr;28(2 and 3-Spec Issue):142-160. doi: 10.1097/FBP.0000000000000247.

α-Melanocyte Stimulating Hormone as a Potential Therapy for Alzheimer`s Disease

Ma K, McLaurin J.

Curr Alzheimer Res. 2017;14(1):18-29. doi: 10.2174/1567205013666160819130641.

The Benefits of Exercise and Metabolic Interventions for the Prevention and Early Treatment of Alzheimer's Disease

Maliszewska-Cyna E, Lynch M, Oore JJ, Nagy PM, Aubert I.

Curr Alzheimer Res. 2017;14(1):47-60. doi: 10.2174/1567205013666160819125400.

Alzheimer's Drug Discovery Maze: A Snap View of the Past Decade's Diverse Pharmacological Targets for the Disorder

Sikazwe D, Yendapally R, Ramsinghani S, Khan M.

Mini Rev Med Chem. 2017;17(3):305-318. doi: 10.2174/1389557516666160822152625.

Novel Multitarget Hybrid Compounds for the Treatment of Alzheimer's Disease

Michalska P, Buendia I, Del Barrio L, Leon R.

Curr Top Med Chem. 2017;17(9):1027-1043. doi: 10.2174/1568026616666160927154116.

Multitarget Tacrine Hybrids with Neuroprotective Properties to Confront Alzheimer's Disease

Spilovska K, Korabecny J, Nepovimova E, Dolezal R, Mezeiova E, Soukup O, Kuca K.

Curr Top Med Chem. 2017;17(9):1006-1026. doi: 10.2174/1568026605666160927152728.

Therapeutic Noninvasive Brain Stimulation in Alzheimer's Disease

Gonsalvez I, Baror R, Fried P, Santarnecchi E, Pascual-Leone A.

Curr Alzheimer Res. 2017;14(4):362-376. doi: 10.2174/1567205013666160930113907.

Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease

Decourt B, Lahiri DK, Sabbagh MN.

Curr Alzheimer Res. 2017;14(4):412-425. doi: 10.2174/1567205013666160930110551.

AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease

Cebers G, Alexander RC, Haeberlein SB, Han D, Goldwater R, Ereshefsky L, Olsson T, Ye N, Rosen L, Russell M, Maltby J, Eketjäll S, Kugler AR.

J Alzheimers Dis. 2017;55(3):1039-1053. doi: 10.3233/JAD-160701.

Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease

Cummings J, Scheltens P, McKeith I, Blesa R, Harrison JE, Bertolucci PH, Rockwood K, Wilkinson D, Wijker W, Bennett DA, Shah RC.

J Alzheimers Dis. 2017;55(3):1131-1139. doi: 10.3233/JAD-160745.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias